PLAU Antikörper (C-Term)
Kurzübersicht für PLAU Antikörper (C-Term) (ABIN2383128)
Target
Alle PLAU Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 396-426, C-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- Urokinase Plasminogen Activator, CT (PLAU, plasminogen activator, urokinase, HGNC:9052, ATF, UPA, URK, u-PA , U-plasminogen activator, antagonist of uPA, plasminogen activator, urinary, urokinase plasminogen activator, urokinase-type plasminogen activator amino-terminal fragment, urokinase-type plasminogen activator precursor)
-
Aufreinigung
- Purified by ammonium sulfate precipitation.
-
Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 396-426 in the C-terminal region of human PLAU, UniProt Accession #P00749.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- PLAU (Plasminogen Activator, Urokinase (PLAU))
-
Andere Bezeichnung
- Urokinase Plasminogen Activator
-
UniProt
- P00749
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagie, Smooth Muscle Cell Migration
Target
-